Steminent Biotherapeutics, Inc (TPEX: 7729)

Market Cap	1.34B
Revenue	n/a
Net Income	n/a
Shares Out	55.80M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,248
Open	25.00
Previous Close	24.95
Day's Range	23.80 - 25.00
52-Week Range	20.00 - 53.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Steminent Biotherapeutics

Steminent Biotherapeutics, Inc., a stem cell research and development company, develops and manufactures novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs. The company focuses on Stemchymal portfolio of cell therapy research and development programs based on allogeneic stem cells that target neurodegenerative and other degenerative diseases. Its product pipeline includes various pre-clinical and clinical stage therapeutic programs for the treatment of spinocerebellar ataxia (PolyQ SCA), osteoarth...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7729